Eli Lilly

+$8.38 (+3.54%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Eli Lilly and other ETFs, options, and stocks.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The firm's products consist of Diabetes, Oncology, Immunology, Neuroscience, and Other therapies.

CEO

David A. Ricks

Employees

35,000

Headquarters

Indianapolis, Indiana

Founded

1876

LLY Key Statistics

Market cap

Price-Earnings ratio

37.42

Dividend yield

1.39

Average volume

2.85M

High today

$245.22

Low today

$235.05

Open price

$235.57

Volume

3.08M

52 Week high

$283.91

52 Week low

$178.58

LLY News

Benzinga16h

Eli Lilly Plans To Invest €400M In Manufacturing Facility In Ireland: Report

Eli Lilly And Co (NYSE: LLY) plans to invest more than €400 million into a new manufacturing facility in Limerick, Ireland, according to a report on gov.ie, a c

Benzinga18h

Eli Lilly Expects FDA Rejection For Expanded Use Baricitinib For Eczema

Based on top-line efficacy results from two pivotal Phase 3 trials Eli Lilly And Co (NYSE: LLY) has decided to discontinue the Phase 3 development program for O

Reuters20h

UPDATE 1-Eli Lilly expects FDA to deny expanded use of arthritis drug for eczema

(Adds details on Lupus study, background) Jan 28 (Reuters) - Eli Lilly and Co said on Friday it expects the U.S. Food and Drug Administration to decline the ap

Analyst ratings

Buy

65.2%

Hold

30.4%

Sell

4.3%

LLY Earnings

$0.00

$0.92

$1.83

$2.75

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Estimated

$2.18 per share

Actual

Available Feb 3, Pre-Market

More LLY News

MarketWatch20h

Eli Lilly Reports Olumiant Setbacks in Lupus, Atopic Dermatitis

By Colin Kellaher Eli Lilly & Co. on Friday reported a pair of setbacks in their efforts to expand Olumiant, its arthritis drug co-developed with Incyte Corp.,

Simply Wall St24h

Eli Lilly Is Paying Out A Larger Dividend Than Last Year

The board of Eli Lilly and Company ( ) has announced that it will be increasing its dividend on the 10th of March to US$0.98. This takes the annual payment to 1

Simply Wall StJan 27

Eli Lilly and Company's Intrinsic Value Is Potentially 81% Above Its Share Price

How far off is Eli Lilly and Company ( ) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced

Fox BusinessJan 27

Michigan AG seeks to probe Eli Lilly for high insulin prices

Michigan's attorney general said Wednesday she sought court approval to investigate Eli Lilly and Co., accusing the drugmaker of charging excessive prices for i

BenzingaJan 25

FDA Rescinds Authorization For Regeneron, Eli Lilly COVID-19 Antibody Treatments: Here's Why

Antibody treatments made by Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Eli Lilly And Co (NYSE: LLY) are not likely to work against the Omicron variant of

BenzingaJan 24

If You Invested $1000 In This Stock 5 Years Ago, Here's How Much You Would Have Today

Eli Lilly (NYSE:LLY) has outperformed the market over the past 5 years by 12.31% on an annualized basis. Buying $1,000 In LLY: 5 years ago, an investor could h

QuartzJan 22

Some US states still pushing ineffective covid antibody treatments

As the omicron variant completes its sweep across the U.S., states with scarce supplies of monoclonal antibody therapies continue to use two treatments that fed